focus -WSS

focus

author：Wikipedia 2025-09-06 01:59:37 - browse：7

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Congressmen charge Covid hearing ‘could have been an email’

hotspot

WSS

Medical device trials still don't enroll enough women, study finds

A $475,000 price tag for a new cancer drug: crazy or meh?

Covid misinformation case heads to Supreme Court

Congressmen charge Covid hearing ‘could have been an email’

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

New report analyzes digital physical therapy solutions' effectiveness

leisure time

focus

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How faith leaders like me can help address America's obesity epidemic

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medical device trials still don't enroll enough women, study finds

Anesthesiologist group: stop taking Ozempic before surgery

How faith leaders like me can help address America's obesity epidemic

After affirmative action ruling, medical educators look to 'holistic review'

Medical device trials still don't enroll enough women, study finds

At least 13 dead in Texas as scorching temps continue

Covid misinformation case heads to Supreme Court

leisure time

General Catalyst, Summa Health deal will turn on physician buy

Commercial surrogacy can be ethical, despite pope’s claims

Some dementia cases could be undiagnosed liver disease

Statins may not be needed by millions of people, study suggests

Congressmen charge Covid hearing ‘could have been an email’

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

entertainment

hotspot

focus